The Star Online ... drugs available to treat hypertension, the first choice for adults with no other health problems would be the angiotensin-converting enzyme (ACE) inhibitors like elanapril and ramipril, and the angiotensin II receptor blockers (ARBs) like losartan ... and more »
QLifePro医療ニュース 京都府立医科大の松原教授が発表した降圧剤『バルサルタン』の論文が次々と撤回された問題において、ノバルティスファーマが外部専門家を招致して第三者検証を行うと発表した。 問題の発端は、松原教授が公開した論文に多くに誤りや疑義の指摘が国内外の専門家から出 ... and more »
MarketWatch (press release) In March 2013, Qualitest received through its partner, Alembic Pharmaceuticals Limited, FDA approval of Valsartan /HCTZ Tablets. Total combined branded and generic sales for Valsartan /HCTZ Tablets in the U.S. for the 12 months ended Dec. 31, 2012 were ... and more »
Wall Street Journal Also during this quarter, topline results from a second Phase III clinical study of Tudorza and formoterol will be reported as will topline results from a Phase III clinical trial from the study of the fixed dose combination of Bystolic and valsartan ... and more »
